More interestingly, in situ melanoma showed a correlation with BDNF expression negativity whereas melanoma metastases were associated with BDNF immunopositivity (70) entrusting to defects in the BDNF signaling pathway the potential ability to link these three diseases. This evidence concerns the gene BDNF and melanoma.